Pomalidomide-C4-COOH is a high-purity E3 Ligase Ligand-Linker Conjugate designed for advanced PROTAC (Proteolysis Targeting Chimera) drug development and targeted protein degradation research. This compound features a pomalidomide-based E3 ligase ligand conjugated to a four-carbon alkyl linker terminated with a carboxylic acid (COOH) functional group, facilitating convenient attachment to target protein ligands or warheads during PROTAC synthesis. As a derivative of pomalidomide, this molecule recruits the CRBN E3 ubiquitin ligase, enabling the formation of bifunctional PROTACs that mediate ubiquitination and subsequent proteasomal degradation of target proteins. Pomalidomide-C4-COOH is widely used in academic and pharmaceutical research to investigate new drug modalities, particularly for challenging or 'undruggable' proteins in oncology, neurodegenerative diseases, and other therapeutic areas. Its reliable performance and modular structure make it an essential building block for custom PROTAC design and molecular glue development.
Structure of 2225940-48-5
* For research and manufacturing use only. Not for human or clinical use.
| Size | Price | Stock | Quantity |
|---|---|---|---|
| -- | $-- | In stock |
Looking for different specifications? Click to request a custom quote!
Capabilities & Facilities
Popular Publications Citing BOC Sciences Products
Background Introduction
Pomalidomide-C4-COOH is a specialized E3 ligase ligand-linker conjugate, which integrates the well-characterized E3 ligase binder pomalidomide with a carboxylic acid-functionalized four-carbon linker. This compound serves as a critical intermediate in the development of targeted protein degradation technologies like PROTACs (Proteolysis Targeting Chimeras), designed to harness the body’s own ubiquitin-proteasome system for the selective elimination of disease-causing proteins.
Mechanism
The mechanism of Pomalidomide-C4-COOH centers around its dual-functionality. Pomalidomide acts as a ligand for the E3 ubiquitin ligase CRBN (Cereblon), effectively recruiting the E3 ligase complex when incorporated into bifunctional molecules. The appended C4 aliphatic linker, terminated with a carboxylic acid group, enables facile conjugation to various target protein ligands or other molecular scaffolds. In a PROTAC construct, Pomalidomide-C4-COOH tethers the E3 ligase to a specific target protein, promoting its ubiquitination and subsequent proteasomal degradation.
Applications
Pomalidomide-C4-COOH is widely used in chemical biology and drug discovery as a fundamental building block for synthesizing PROTAC molecules. Its applications include the development of custom PROTACs for degrading oncogenic proteins, creating molecular probes to study protein function, and contributing to the validation of novel therapeutic targets. Researchers select Pomalidomide-C4-COOH due to its reliability, efficiency in E3 ligase recruitment, and ease of chemical modification, making it an essential tool in the toolkit for targeted protein degradation strategies.
* Our calculator is based on the following equation:
Concentration (start) x Volume (start) = Concentration (final) x Volume (final)
It is commonly abbreviated as: C1V1 = C2V2
Please contact us with any specific requirements and we will get back to you as soon as possible.